Duration Of Infection-Derived Immunity To Cholera

Journal of Infectious Diseases

Volumn 143, Issue 6, 1981, Pages 818-820

  Levine, M M ^a   Black, R E ^a   Clements, M L ^a   Cisneros, L ^a   Nalin, D R ^a   Young, C R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; VACCINE;

IMMUNOGLOBULIN G BLOOD LEVEL; IN VITRO STUDY; NORMAL HUMAN; THEORETICAL STUDY; VIBRIO CHOLERAE;

ANTIBODIES, BACTERIAL; ANTITOXINS; BACTERIAL INFECTIONS; CHOLERA; HUMANS; IMMUNITY; TIME FACTORS; VIBRIO CHOLERAE;

EID: 0019410011     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/143.6.818     Document Type: Article

References (15)

1. Joo, I. Cholera vaccines. In D. Barua and W. Burrows [ed.]. Cholera. Saunders, Philadelphia, 1974, p. 333-355.
2. Curlin, G., Levine, R., Aziz, K. M. A., Rahman, A. S. M. M., Verwey, W. F. Field trial of cholera toxoid. In Proceedings of the 11th Joint Conference on Cholera. U.S.-Japan Cooperative Medical Science Program, Washington, D.C., 1974, p. 314-329.
3. Levine, M. M., Nalin, D. R., Craig, J. P., Hoover, D., Bergquist, E. J., Waterman, D., Holley, H. P., Hor- nick, R. B., Pierce, N. P., Libonati, J. P. Immunity to cholera in man: relative role of antibacterial versus antitoxic immunity. Trans. R. Soc. Trop. Med. Hyg. 73:3-9, 1979.
4. Levine, M. M. Immunity to cholera as evaluated in volunteers. In O. Ouchterlony and J. Holmgren [ed.]. Cholera and related diarrheas. Karger, Basel, 1980, p. 195-203.
5. Woodward, W. E. Cholera reinfection in man. J. Infect. Dis. 123:61-66, 1971.
6. Mosley, W. H., Benenson, A. S., Barui, R. A serological survey for cholera antibodies in rural East Pakistan. I. The distribution of antibody in the control population of a cholera vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera. Bull. W.H.O. 38:327-334, 1968.
7. Merson, M. H., Black, R. E., Kahn, M., Huq, I. Epidemiology of cholera and enterotoxigenic Escherichia coli diarrhoea. In O. Ouchterlony and J. Holmgren [ed.]. Cholera and related diarrheas. Karger, Basel, 1980, p. 34-45.
8. Cash, R. A., Music, S. I., Libonati, J. P., Snyder, M. J., Wenzel, R. P., Hornick, R. B. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J. Infect. Dis. 129:45-52, 1974.
9. Rennels, M. B., Levine, M. M., Daya, V., Angle, P., Young, C. Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories. J. Infect. Dis. 142:328-331, 1980.
10. Levine, M. M., Hughes, T. P., Young, C. R., O’Donnell, S., Craig, J. P., Holley, H. P., Bergquist, E. J. Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally. Infec. Immun. 21:158-162, 1978.
11. Young, C. R., Levine, M. M., Craig, J. P., Robins-Browne, R. Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: methods and correlation with rabbit skin vascular permeability factor technique. Infec. Immun. 27:492-496, 1980.
12. Robins-Browne, R. M., Young, C. R., Levine, M. M., Craig, J. P. Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: sensitivity and specificity. Infec. Immun. 27: 497-500, 1980.
13. Svennerholm, A.-M., Holmgren, J. Synergistic protecttive effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoids. Infec. Immun. 13:735-740, 1976.
14. Honda, T., Finkelstein, R. A. Selection and character istics of a Vibrio cholerae mutant lacking the A (ADP- ribosylating) portion of the cholera enterotoxin. Proc. Natl. Acad. Sci. U.S.A. 76:2052-2056, 1979.
15. Levine, M. M., Black, R. E., Clements, M. L., Nalin, D. R., Cisneros, L., Finkelstein, R. A. Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: a review. In J. Holmgren and T. Holme [ed.]. Acute enteric infections in children: new prospects for treatment and prevention. Elsevier, Amsterdam, 1981 (in press).